ALPMF Stock: Astellas Pharma Inc. Stock Price, Analysis & Insights
Get live ALPMF stock price $13.25, comprehensive Astellas Pharma Inc. stock analysis, charts, news, and expert forecast. Real-time ALPMF stock data and investment insights.
Loading chart data...
Astellas Pharma Inc. (ALPMF) Overview
Astellas Pharma Inc. (ALPMF) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - General industry . As of the latest trading session, ALPMF trades at $13.25 with a market capitalization of 23.74B . Over the past 52 weeks, ALPMF has traded between $9.34 and $17.85 , with the current price positioned at approximately 46% of this range . The stock c...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - General)
- Market cap: 23.74B
- Current price: $13.25
- 52-week range: $9.34 - $17.85
- P/E ratio: 13.12
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Astellas Pharma Inc. operates as a global pharmaceutical enterprise, encompassing the development, manufacturing, distribution, and commercialization of medicinal products across international markets. Its diverse portfolio features prominent therapi...
Company Information
- CEO
- Naoki Okamura
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Employees
- 14754
Contact Information
- Website
- https://www.astellas.com
- Address
- 2-5-1, Nihonbashi-Honcho
- Country
- JP
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 13.1)
✓ Lower volatility stock (Beta: 0.07) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Astellas Pharma Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Astellas Pharma Inc.
- ⚠Investors should consider how Astellas Pharma Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
23.74B
P/E Ratio (TTM)
13.12
Beta
0.07
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare ALPMF with peer companies:
- Price
- $8.03
- Market cap
- 9.47B
- Price
- $1.05
- Market cap
- 11.98B
- Price
- $3.61
- Market cap
- 10.38B
- Price
- $45.17
- Market cap
- 12.13B
- Price
- $5.69
- Market cap
- 14.95B
- Price
- $249.00
- Market cap
- 15.29B
- Price
- $37.99
- Market cap
- 21.38B
- Price
- $50.40
- Market cap
- 14.97B
- Price
- $4.40
- Market cap
- 18.22B
- Price
- $7.49
- Market cap
- 15.44B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.